mPEG-PLGA-COOH, MW x 10K, n 2K is a biodegradable, amphiphilic block copolymer composed of methoxy polyethylene glycol (mPEG) and poly(lactic-co-glycolic acid) (PLGA), featuring a terminal carboxylic acid group. The polymer combines the hydrophilic properties of mPEG with the biodegradable characteristics of PLGA, supporting nanoparticle formulation, controlled drug delivery, and biomaterials development, while its reactive carboxyl group enables further functionalization and bioconjugation with suitable amine-containing molecules.
Key Features and Benefits
- Amphiphilic Block Copolymer: Combines hydrophilic mPEG and hydrophobic PLGA segments to specifically support polymeric nanoparticle and micelle formation.
- Defined Molecular Weight Configuration: Features an approximately 10 kDa PLGA segment and a 2 kDa mPEG segment, providing a nominal combined molecular weight of approximately 12 kDa.
- Biodegradable PLGA Component: Contains hydrolytically degradable polyester linkages that support gradual polymer degradation in compatible aqueous environments.
- Hydrophilic mPEG Segment: Provides a hydrated polymer component that can improve colloidal stability and reduce nonspecific interactions in appropriately designed formulations.
- Terminal Carboxylic Acid Group: Offers a reactive COOH functionality for covalent coupling with amine-containing compounds through suitable conjugation chemistry.
- Nanoparticle Formation Capability: Supports the preparation of polymeric nanoparticles and other self-assembled delivery systems using validated formulation methods.
- Drug Encapsulation Compatibility: Enables investigation of hydrophobic drug encapsulation within PLGA-containing polymeric carriers.
- Controlled Release Potential: Supports development of delivery systems with adjustable release characteristics based on polymer composition, degradation, and formulation conditions.
- Bioconjugation Versatility: Enables attachment of compatible peptides, targeting ligands, and other functional molecules for specialized nanoparticle applications.
Applications
- Polymeric Nanoparticle Formulation: Supports preparation of biodegradable polymeric nanoparticles for drug delivery and nanomedicine research.
- Controlled Drug Delivery: Enables development of polymer-based carriers specifically designed to investigate sustained and controlled release of encapsulated compounds.
- Hydrophobic Drug Encapsulation: Supports formulation studies involving poorly water-soluble compounds within PLGA-containing delivery systems.
- Targeted Drug Delivery Research: Provides a functional polymer platform for conjugating suitable targeting ligands to drug delivery carriers.
- Peptide and Biomolecule Conjugation: Enables covalent attachment of compatible amine-functionalized peptides and other biomolecules through carboxyl-mediated coupling reactions.
- Polymeric Micelle Development: Supports investigation of amphiphilic polymer self-assembly and micellar structures under suitable formulation conditions.
- Nanoparticle Surface Functionalization: Provides reactive carboxyl groups specifically for introducing functional molecules and modifying particle surface properties.
- Biodegradable Biomaterials Research: Supports development of polymeric materials for tissue engineering, regenerative medicine, and related research applications.
- Nanomedicine Research: Enables investigation of polymeric carrier stability, drug loading, release kinetics, and particle behavior in experimental systems.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and heat. Minimize temperature fluctuations to prevent premature polymer degradation.
- Handling: Use clean, dry equipment and appropriate protective gear. Dissolve in compatible solvents, such as DMSO, DMF, acetone, or dichloromethane, after confirming solubility.
- Nanoparticle Preparation: Prepare nanoparticles using nanoprecipitation, emulsification, or solvent evaporation. Optimize polymer concentration and processing conditions to achieve desired particle properties.
- Bioconjugation and Analysis: Activate terminal carboxyl groups using EDC/NHS chemistry for coupling with primary amines. Subsequently, evaluate nanoparticle size, stability, drug loading, and polymer integrity using appropriate analytical methods.
mPEG-PLGA-COOH, MW x 10K, n 2K combines biodegradable PLGA, hydrophilic mPEG, and reactive carboxylic acid functionality in a versatile amphiphilic polymer platform and specifically supports polymeric nanoparticle development, controlled drug delivery, peptide conjugation, surface functionalization, and biomaterials research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
